Home › Companies › Abeona Therapeutics Inc. › 2025-2026

Abeona Therapeutics Inc. 2025-2026 Proxy Voting Records

Compiled from SEC Form N-PX filings and Abeona Therapeutics Inc.’s Form 8-K, filed 2026-06-12 (Item 5.07 on EDGAR). Page generated 02 October 2026.

8Reported items
111Asset managers
741Fund votes
2026-06-12Meeting date

Proxy season: 2025-2026

Explore Abeona Therapeutics Inc. in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by Abeona Therapeutics Inc.

These tallies are Abeona Therapeutics Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2026-06-12 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

Abeona Therapeutics Inc. — official shareholder meeting results, meeting held 2026-06-12
Ballot item	For	Against	Abstain	Withheld	Broker non-votes	Outcome
Elect Director: Keith A. Goldan	28,305,958	1,352,589	70,514	--	12,256,230	Majority: yes
Elect Director: Bernhardt G. Zeiher, M.D.	28,131,990	1,577,444	19,627	--	12,256,230	Majority: yes
Proposal 2. Advisory Vote on Compensation of Named Executive Officers. An advisory vote to approve the compensation of the Company's named executive officers was approved by the following votes:	23,300,653	4,511,866	1,916,542	--	12,256,230	Majority: yes

Source: Abeona Therapeutics Inc., Form 8-K, filed with the SEC on 2026-06-12 — read the filing on EDGAR.

How asset managers voted at the Abeona Therapeutics Inc. 2025-2026 meeting

Each item below shows how the 111 asset managers that disclosed a Abeona Therapeutics Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Abeona Therapeutics Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. To approve, on an advisory basis, the compensation of the Company's named executive officers.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

84% Majority: yes · of votes cast

FOR 84%AGAINST 16%

FOR: 23,300,653AGAINST: 4,511,866

Abeona Therapeutics Inc.’s own tally for this item (“Proposal 2. Advisory Vote on Compensation of Named Executive Officers. An advisory vote to approve the compensation of the Company's named executive officers was approved by the following votes:”): 23,300,653 for, 4,511,866 against, per its Form 8-K filed 2026-06-12 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 56,995,144 outstanding shares: 41% for, 8% against (48.8% of the company cast a for/against vote).

The 111 asset managers below cast 84% of the shares they voted on this item FOR (13,777,207 for, 2,709,690 against).

FOR 84%AGAINST 16%

FOR: 13,777,207 (83.6%)AGAINST: 2,709,690 (16.4%)ABSTAIN: 1 (0.0%)

Largest asset managers voting on “To approve, on an advisory basis, the compensation of the Company's named executive officers.” at Abeona Therapeutics Inc., 2025-2026
Asset manager	For	Against	Abstain	Vote
Nantahala Capital Management, LLC	4,385,779	0	0	For
MONTANOVA CAPITAL, LLC	2,553,916	0	0	For
AIGH Capital Management LLC	2,398,946	0	0	For
NAN FUNG TRINITY (HK) Ltd	0	956,770	0	Against
AWM Investment Company, Inc.	803,130	0	0	For
Stonepine Capital Management, LLC	746,587	0	0	For
Vanguard	605,774	314	1	For
Simplify Exchange Traded Funds	500,342	0	0	For
KENNEDY CAPITAL MANAGEMENT LLC	0	467,379	0	Against
J. Goldman & Co LP	399,083	0	0	For
State Street	386,915	3,942	0	For
683 Capital Management, LLC	0	383,216	0	Against
SILVERARC CAPITAL MANAGEMENT, LLC	0	320,105	0	Against
BlackRock	299,129	2,314	0	For
Northern Trust	201,415	1,756	0	For
DE Shaw	0	99,083	0	Against
WisdomTree	0	97,228	0	Against
BALYASNY ASSET MANAGEMENT L.P.	94,085	0	0	For
PARAMETRIC PORTFOLIO ASSOCIATES LLC	69,316	0	0	For
Rangeley Capital, LLC	0	60,000	0	Against
MELLON INVESTMENTS Corp	0	58,895	0	Against
AQR	0	45,891	0	Against
Fidelity	39,714	0	0	For
Goldman Sachs	39,569	0	0	For
Harbor ETF Trust	35,310	0	0	For

Showing the 25 largest of 111 asset managers. See all 111 in the interactive database.

2. To approve an increase in the number of shares reserved for issuance under the Second Amended and Restated Abeona Therapeutics Inc. 2023 Equity Incentive Plan from 8,400,000 to 11,500,000.

COMPENSATION

94% fund support · no official result

FOR 94%

The 36 asset managers below cast 94% of the shares they voted on this item FOR (1,465,300 for, 86,286 against).

FOR: 1,465,300 (94.4%)AGAINST: 86,286 (5.6%)

Largest asset managers voting on “To approve an increase in the number of shares reserved for issuance under the Second Amended and Restated Abe” at Abeona Therapeutics Inc., 2025-2026
Asset manager	For	Against	Vote
Vanguard	563,467	40	For
Simplify Exchange Traded Funds	500,342	0	For
BlackRock	129,498	0	For
WisdomTree	97,228	0	For
Rangeley Capital, LLC	0	60,000	Against
Harbor ETF Trust	35,310	0	For
Lincoln Financial	29,500	0	For
Fidelity	11,782	12,546	Against
Global X	20,790	0	For
Goldman Sachs	17,744	0	For
Equitable	9,281	1,703	For
Bridge Builder Trust	8,480	0	For
American Century	0	7,538	Against
Charles Schwab	6,346	0	For
AIG/SunAmerica	6,314	0	For
SEI	4,700	0	For
Calvert	0	4,459	Against
John Hancock	3,733	0	For
Venerable Variable Insurance Trust	3,618	0	For
Principal	3,108	0	For
Pacific Life	3,102	0	For
Voya	2,554	0	For
ProShares	2,295	0	For
State Street	1,820	0	For
Brinker Capital Destinations Trust	1,404	0	For

Showing the 25 largest of 36 asset managers. See all 36 in the interactive database.

3. Election of three Class 1 Directors for a three-year term: Bernhardt G. Zeiher, M.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%

FOR: 28,131,990AGAINST: 1,577,444

Abeona Therapeutics Inc.’s own tally for this item (“Elect Director: Bernhardt G. Zeiher, M.D.”): 28,131,990 for, 1,577,444 against, per its Form 8-K filed 2026-06-12 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 56,995,144 outstanding shares: 49.4% for, 3% against (52.1% of the company cast a for/against vote).

The 35 asset managers below cast 99.9% of the shares they voted on this item FOR (1,491,585 for, 1 against).

FOR 99.9%

FOR: 1,491,585 (100.0%)AGAINST: 1 (0.0%)

Largest asset managers voting on “Election of three Class 1 Directors for a three-year term: Bernhardt G. Zeiher, M.D.” at Abeona Therapeutics Inc., 2025-2026
Asset manager	For	Against	Vote
Vanguard	563,506	1	For
Simplify Exchange Traded Funds	500,342	0	For
BlackRock	129,498	0	For
WisdomTree	97,228	0	For
Harbor ETF Trust	35,310	0	For
Lincoln Financial	29,500	0	For
Fidelity	24,328	0	For
Global X	20,790	0	For
Goldman Sachs	17,744	0	For
Equitable	10,984	0	For
Bridge Builder Trust	8,480	0	For
American Century	7,538	0	For
Charles Schwab	6,346	0	For
AIG/SunAmerica	6,314	0	For
SEI	4,700	0	For
Calvert	4,459	0	For
John Hancock	3,733	0	For
Venerable Variable Insurance Trust	3,618	0	For
Principal	3,108	0	For
Pacific Life	3,102	0	For
Voya	2,554	0	For
ProShares	2,295	0	For
State Street	1,820	0	For
Brinker Capital Destinations Trust	1,404	0	For
PENN SERIES FUNDS INC	1,400	0	For

Showing the 25 largest of 35 asset managers. See all 35 in the interactive database.

4. Election of three Class 1 Directors for a three-year term: Keith A. Goldan

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%

FOR: 28,305,958AGAINST: 1,352,589

Abeona Therapeutics Inc.’s own tally for this item (“Elect Director: Keith A. Goldan”): 28,305,958 for, 1,352,589 against, per its Form 8-K filed 2026-06-12 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 56,995,144 outstanding shares: 49.7% for, 2% against (52.0% of the company cast a for/against vote).

The 35 asset managers below cast 99.9% of the shares they voted on this item FOR (1,491,585 for, 1 against).

FOR 99.9%

FOR: 1,491,585 (100.0%)AGAINST: 1 (0.0%)

Largest asset managers voting on “Election of three Class 1 Directors for a three-year term: Keith A. Goldan” at Abeona Therapeutics Inc., 2025-2026
Asset manager	For	Against	Vote
Vanguard	563,506	1	For
Simplify Exchange Traded Funds	500,342	0	For
BlackRock	129,498	0	For
WisdomTree	97,228	0	For
Harbor ETF Trust	35,310	0	For
Lincoln Financial	29,500	0	For
Fidelity	24,328	0	For
Global X	20,790	0	For
Goldman Sachs	17,744	0	For
Equitable	10,984	0	For
Bridge Builder Trust	8,480	0	For
American Century	7,538	0	For
Charles Schwab	6,346	0	For
AIG/SunAmerica	6,314	0	For
SEI	4,700	0	For
Calvert	4,459	0	For
John Hancock	3,733	0	For
Venerable Variable Insurance Trust	3,618	0	For
Principal	3,108	0	For
Pacific Life	3,102	0	For
Voya	2,554	0	For
ProShares	2,295	0	For
State Street	1,820	0	For
Brinker Capital Destinations Trust	1,404	0	For
PENN SERIES FUNDS INC	1,400	0	For

Showing the 25 largest of 35 asset managers. See all 35 in the interactive database.

5. Election of three Class 1 Directors for a three-year term: Michael Amoroso

DIRECTOR ELECTIONS

Combines 2 wordings of this item as funds reported it.

87% fund support · no official result

FOR 87%13%

The 35 asset managers below cast 87% of the shares they voted on this item FOR (1,302,585 for, 189,001 against).

FOR: 1,302,585 (87.3%)AGAINST: 189,001 (12.7%)

Largest asset managers voting on “Election of three Class 1 Directors for a three-year term: Michael Amoroso” at Abeona Therapeutics Inc., 2025-2026
Asset manager	For	Against	Vote
Vanguard	563,063	444	For
Simplify Exchange Traded Funds	500,342	0	For
BlackRock	0	129,498	Against
WisdomTree	97,228	0	For
Harbor ETF Trust	35,310	0	For
Lincoln Financial	29,500	0	For
Fidelity	11,782	12,546	Against
Global X	20,790	0	For
Goldman Sachs	17,744	0	For
Equitable	0	10,984	Against
Bridge Builder Trust	0	8,480	Against
American Century	7,538	0	For
Charles Schwab	6,346	0	For
AIG/SunAmerica	0	6,314	Against
SEI	4,700	0	For
Calvert	0	4,459	Against
John Hancock	0	3,733	Against
Venerable Variable Insurance Trust	3,618	0	For
Principal	0	3,108	Against
Pacific Life	0	3,102	Against
Voya	0	2,554	Against
ProShares	0	2,295	Against
State Street	1,820	0	For
Brinker Capital Destinations Trust	1,404	0	For
PENN SERIES FUNDS INC	1,400	0	For

Showing the 25 largest of 35 asset managers. See all 35 in the interactive database.

6. To approve an amendment to the Company's Restated Certificate of Incorporation to remove the advance notice provision for director nominations.

CORPORATE GOVERNANCE

99.9% fund support · no official result

FOR 99.9%

The 35 asset managers below cast 99.9% of the shares they voted on this item FOR (1,491,546 for, 40 against).

FOR: 1,491,546 (100.0%)AGAINST: 40 (0.0%)

Largest asset managers voting on “To approve an amendment to the Company's Restated Certificate of Incorporation to remove the advance notice pr” at Abeona Therapeutics Inc., 2025-2026
Asset manager	For	Against	Vote
Vanguard	563,467	40	For
Simplify Exchange Traded Funds	500,342	0	For
BlackRock	129,498	0	For
WisdomTree	97,228	0	For
Harbor ETF Trust	35,310	0	For
Lincoln Financial	29,500	0	For
Fidelity	24,328	0	For
Global X	20,790	0	For
Goldman Sachs	17,744	0	For
Equitable	10,984	0	For
Bridge Builder Trust	8,480	0	For
American Century	7,538	0	For
Charles Schwab	6,346	0	For
AIG/SunAmerica	6,314	0	For
SEI	4,700	0	For
Calvert	4,459	0	For
John Hancock	3,733	0	For
Venerable Variable Insurance Trust	3,618	0	For
Principal	3,108	0	For
Pacific Life	3,102	0	For
Voya	2,554	0	For
ProShares	2,295	0	For
State Street	1,820	0	For
Brinker Capital Destinations Trust	1,404	0	For
PENN SERIES FUNDS INC	1,400	0	For

Showing the 25 largest of 35 asset managers. See all 35 in the interactive database.

7. Ratify the appointment of Deloitte & Touche LLP as our independent registered public accountant for the fiscal year ending December 31, 2026.

AUDIT-RELATED

100% fund support · no official result

FOR 100%

The 25 asset managers below cast 100% of the shares they voted on this item FOR (777,634 for, 0 against).

FOR: 777,634 (100.0%)

Largest asset managers voting on “Ratify the appointment of Deloitte & Touche LLP as our independent registered public accountant for the fiscal” at Abeona Therapeutics Inc., 2025-2026
Asset manager	For	Vote
Vanguard	562,443	For
WisdomTree	97,228	For
Lincoln Financial	29,500	For
Fidelity	24,328	For
Goldman Sachs	17,744	For
Equitable	10,984	For
American Century	7,538	For
AIG/SunAmerica	6,314	For
Calvert	4,459	For
Principal	3,108	For
Pacific Life	3,102	For
Voya	2,554	For
ProShares	2,295	For
State Street	1,820	For
Brinker Capital Destinations Trust	1,404	For
PENN SERIES FUNDS INC	1,400	For
TIAA	568	For
Guggenheim	398	For
Nationwide	141	For
T. Rowe Price	106	For
DWS	80	For
Victory Capital	56	For
Columbia Threadneedle	46	For
Dimensional	17	For
Brighthouse	1	For

8. To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.

AUDIT-RELATED

100% fund support · no official result

FOR 100%

The 11 asset managers below cast 100% of the shares they voted on this item FOR (713,952 for, 0 against).

FOR: 713,952 (100.0%)

Largest asset managers voting on “To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for th” at Abeona Therapeutics Inc., 2025-2026
Asset manager	For	Vote
Simplify Exchange Traded Funds	500,342	For
BlackRock	129,498	For
Harbor ETF Trust	35,310	For
Global X	20,790	For
Bridge Builder Trust	8,480	For
Charles Schwab	6,346	For
SEI	4,700	For
John Hancock	3,733	For
Venerable Variable Insurance Trust	3,618	For
Vanguard	1,064	For
QUANTITATIVE MASTER SERIES LLC	71	For

Largest Abeona Therapeutics Inc. shareholders voting in 2025-2026

Ranked by the number of Abeona Therapeutics Inc. shares each manager voted on the most widely held ballot item of the 2025-2026 meeting, shown as a share of the 56,995,144 shares outstanding at the time of that meeting.

Top Abeona Therapeutics Inc. shareholders by shares voted, 2025-2026
#	Asset manager	% of shares outstanding
1	Nantahala Capital Management, LLC	7.70%
2	MONTANOVA CAPITAL, LLC	4.48%
3	AIGH Capital Management LLC	4.21%
4	NAN FUNG TRINITY (HK) Ltd	1.68%
5	AWM Investment Company, Inc.	1.41%
6	Stonepine Capital Management, LLC	1.31%
7	Vanguard	1.06%
8	Simplify Exchange Traded Funds	0.88%
9	KENNEDY CAPITAL MANAGEMENT LLC	0.82%
10	J. Goldman & Co LP	0.70%

Reported Abeona Therapeutics Inc. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

Abeona Therapeutics Inc. beneficial owners on record for the 2025-2026 proxy season
Holder	% outstanding	Disclosure
Nantahala Capital Management, LLC	10.13%	13G
NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP	5.85%	13G
BlackRock	5.61%	13F
Funicular Funds, LP	5.28%	13G
Daniel Kaufman	5.16%	13G
Vanguard Group	4.84%	13F
Vishwas Seshadri	2.56%	DEF14A
Goldman Sachs	1.98%	13F
State Street	1.68%	13F
Joseph Vazzano	1.00%	DEF14A

Percentages above are of 56,995,144 shares outstanding, as reported by Abeona Therapeutics Inc. on its Form 10-Q dated 2026-05-08 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Abeona Therapeutics Inc.’s 10-Q dated 2026-05-08. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At Abeona Therapeutics Inc.'s shareholder meeting held 2026-06-12, in the 2025-2026 proxy season, 111 asset managers reported how they voted in their SEC Form N-PX filings, covering 741 separate fund positions. Their filings are grouped here into 8 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — To approve, on an advisory basis, the compensation of the Company's named executive officers. — FOR was 84% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: Abeona Therapeutics Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2026-06-12.

Abeona Therapeutics Inc. proxy season coverage: 2025-2026 (this page).